Magic mushrooms are generally associated with the rave scene, or festival goers having a trippy experience. But what if these mushrooms are the future of mental health? Millions and millions have already been poured into research globally to measure the effects of the active ingredient, psilocybin.
In this episode of The Next Stage Katerina Mal-eev-ska, co-founder of mental healthcare company Compass Pathways, talks about the exciting new results from her company’s psilocybin trial.
20 percent of people experiencing what is known as ‘treatment resistant depression’ responded to psilocybin despite having not responded for years or even decades to currently approved depression treatments, says Katerina. Keep listening for more details on this groundbreaking new study.
"The best technology conference on the planet".
Follow us on Twitter, Instagram and Linkedin.